Yes, I am well aware of all of this. But this report indicates that PLS, shouldn't face insolvency, be forced to use a CR, or go begging to the Chinese (CATL) for help in the next 12-18 months, which is a huge deal. That was my primary concern with this company. Now, it looks like PLS might be well positioned to take off if spodumene prices return to a sane level in FY 2021/2022. Almost inclined to change sentiment to buy.
Ann: Quarterly Activities Report, page-11
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.99 |
Change
0.010(0.34%) |
Mkt cap ! $9.000B | |||
| Open | High | Low | Value | Volume |
| $2.93 | $3.01 | $2.89 | $104.7M | 35.12M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 11874 | $2.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.99 | 65336 | 3 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| PLS (ASX) Chart |